Sotera Health completes opt-in for $408M EO settlement; 99.7% of eligible claimants join

Sotera Health Co

879 of 882 eligible claimants opted into the January 2023 ethylene oxide settlement.
Sterigenics waived walkaway rights and will proceed with 879 settling claimants.
Three opt-out claimants will proceed to pretrial discovery per Circuit Court schedule.
Court entered good-faith settlement order; funds disbursed ten days after order.
Company will incur no additional charges beyond those recognized in Q4 2022.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Sotera Health Co amended Amendment with JPMorgan Chase Bank, N.A., as First Lien Administrative Agent (effective 2023-06-22).

Action: amendment
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A., as First Lien Administrative Agent
Effective: 2023-06-22

Exact text from the filing

On June 22, 2023, Sotera Health Company (the “Company”) and Sotera Health Holdings, LLC (“SHH”) entered into an amendment (the “Amendment”) to the First Lien Credit Agreement, dated as of December 13, 2019, by and among the Company, SHH, certain subsidiaries of the Company, JPMorgan Chase Bank, N.A., as First Lien Administrative Agent and the lenders and issuing banks party thereto (the “Credit Agreement”).

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-23-000039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.